Matrix;
p17
|
Facilitates targeting of Gag–Pol and Gag to the plasma membrane
Incorporation of Env into virions
Associated with reverse transcription and the pre-integration complex during early stages of replication
Binds tRNA (transfer RNA), rRNA (ribosomal RNA) and heterologous DNA
Acts as a viral cytokine to promote a favourable network of virus- and host-derived stimulatory factors for optimal infection and replication
|
Capsid;
p24
|
Houses viral RNA and core-associated proteins
Interaction with several cellular host factors and/or metabolites including cyclophilin A and inositol hexaphosphate (IP6)
Interacts with cellular nucleoporins to allow import of the PIC
The precursor PR55 Gag capsid domain and the mature p24 capsid display several functional roles in the viral replication cycle, including assembly, reverse transcription, integration and infectivity
|
Nucleocapsid;
p7
|
Packages viral RNA into rapidly assembling, immature viral particles
Ability to renature nucleic acids
Stimulates tRNALys binding to the primer binding site, initiates reverse transcription from the bound tRNALys and partakes in strand transfer
Possesses nucleic binding and chaperone activity in the conversion of gRNA (genomic RNA) to viral dsDNA (double-stranded DNA)
|
p6
|
Flexible docking site for cellular host factors, specifically ALIX and TSG101
Contributes to RNA binding specificity of gRNA of Gag PR55
Incorporation of viral accessory protein, Vpr
Primary phosphoprotein
Substrate for virus-associated kinases such as Erk-2 and Elk tyrosine kinases
Contributes to RNA binding specificity of PR55 Gag
|
SP1
|
|
SP2
|
Plays a role in the incorporation of Pol and Gag in the immature virus particles
Effect on the stability of nucleocapsid-RNA (NC–RNA) complexes and thus viral infectivity
May have an effect on proviral integration when present as the p9 NC|SP2 peptide
|